259 related articles for article (PubMed ID: 29216597)
21. ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells.
Talekar MK; Allen JE; Dicker DT; El-Deiry WS
Cell Cycle; 2015 Aug; 14(15):2422-8. PubMed ID: 26030065
[TBL] [Abstract][Full Text] [Related]
22. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Pierce SR; Fang Z; Yin Y; West L; Asher M; Hao T; Zhang X; Tucker K; Staley A; Fan Y; Sun W; Moore DT; Xu C; Tsai YH; Parker J; Prabhu VV; Allen JE; Lee D; Zhou C; Bae-Jump V
J Exp Clin Cancer Res; 2021 Feb; 40(1):61. PubMed ID: 33557912
[TBL] [Abstract][Full Text] [Related]
23. Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells.
Zhang Y; Tapinos N; Lulla R; El-Deiry WS
Am J Cancer Res; 2024; 14(5):2453-2464. PubMed ID: 38859853
[TBL] [Abstract][Full Text] [Related]
24. Microarray analysis reveals ONC201 mediated differential mechanisms of CHOP gene regulation in metastatic and nonmetastatic colorectal cancer cells.
Al Madhoun A; Haddad D; Al Tarrah M; Jacob S; Al-Ali W; Nizam R; Miranda L; Al-Rashed F; Sindhu S; Ahmad R; Bitar MS; Al-Mulla F
Sci Rep; 2021 Jun; 11(1):11893. PubMed ID: 34088951
[TBL] [Abstract][Full Text] [Related]
25. ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer.
Farmaki E; Nath A; Emond R; Karimi KL; Grolmusz VK; Cosgrove PA; Bild AH
Elife; 2023 Sep; 12():. PubMed ID: 37772709
[TBL] [Abstract][Full Text] [Related]
26. Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer.
Pornour M; Ahangari G; Hejazi SH; Ahmadkhaniha HR; Akbari ME
Asian Pac J Cancer Prev; 2014; 15(23):10339-43. PubMed ID: 25556472
[TBL] [Abstract][Full Text] [Related]
27. Biological activity of weekly ONC201 in adult recurrent glioblastoma patients.
Arrillaga-Romany I; Odia Y; Prabhu VV; Tarapore RS; Merdinger K; Stogniew M; Oster W; Allen JE; Mehta M; Batchelor TT; Wen PY
Neuro Oncol; 2020 Jan; 22(1):94-102. PubMed ID: 31702782
[TBL] [Abstract][Full Text] [Related]
28. Maternal deprivation-caused behavioral abnormalities in adult rats relate to a non-methylation-regulated D2 receptor levels in the nucleus accumbens.
Zhu X; Li T; Peng S; Ma X; Chen X; Zhang X
Behav Brain Res; 2010 Jun; 209(2):281-8. PubMed ID: 20144661
[TBL] [Abstract][Full Text] [Related]
29. ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.
Yuan X; Kho D; Xu J; Gajan A; Wu K; Wu GS
Oncotarget; 2017 Mar; 8(13):21626-21638. PubMed ID: 28423492
[TBL] [Abstract][Full Text] [Related]
30. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases.
Kline CL; Van den Heuvel AP; Allen JE; Prabhu VV; Dicker DT; El-Deiry WS
Sci Signal; 2016 Feb; 9(415):ra18. PubMed ID: 26884600
[TBL] [Abstract][Full Text] [Related]
31. Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma.
He L; Bhat K; Ioannidis A; Zhang L; Nguyen NT; Allen JE; Nghiemphu PL; Cloughesy TF; Liau LM; Kornblum HI; Pajonk F
Radiother Oncol; 2021 Aug; 161():140-147. PubMed ID: 34097975
[TBL] [Abstract][Full Text] [Related]
32. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.
Barroso-Chinea P; Luis-Ravelo D; Fumagallo-Reading F; Castro-Hernandez J; Salas-Hernandez J; Rodriguez-Nuñez J; Febles-Casquero A; Cruz-Muros I; Afonso-Oramas D; Abreu-Gonzalez P; Moratalla R; Millan MJ; Gonzalez-Hernandez T
Autophagy; 2020 Jul; 16(7):1279-1295. PubMed ID: 31538542
[TBL] [Abstract][Full Text] [Related]
33. First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors.
Stein MN; Bertino JR; Kaufman HL; Mayer T; Moss R; Silk A; Chan N; Malhotra J; Rodriguez L; Aisner J; Aiken RD; Haffty BG; DiPaola RS; Saunders T; Zloza A; Damare S; Beckett Y; Yu B; Najmi S; Gabel C; Dickerson S; Zheng L; El-Deiry WS; Allen JE; Stogniew M; Oster W; Mehnert JM
Clin Cancer Res; 2017 Aug; 23(15):4163-4169. PubMed ID: 28331050
[No Abstract] [Full Text] [Related]
34. ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer.
Lev A; Lulla AR; Ross BC; Ralff MD; Makhov PB; Dicker DT; El-Deiry WS
Mol Cancer Res; 2018 May; 16(5):754-766. PubMed ID: 29588330
[TBL] [Abstract][Full Text] [Related]
35. Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.
Allen JE; Prabhu VV; Talekar M; van den Heuvel AP; Lim B; Dicker DT; Fritz JL; Beck A; El-Deiry WS
Cancer Res; 2015 Apr; 75(8):1668-74. PubMed ID: 25681273
[TBL] [Abstract][Full Text] [Related]
36. Expression Profiles of Dopamine-Related Genes and miRNAs Regulating Their Expression in Breast Cancer.
Sirek T; Sirek A; Borawski P; Ryguła I; Król-Jatręga K; Opławski M; Boroń D; Chalcarz M; Ossowski P; Dziobek K; Zmarzły N; Boroń K; Mickiewicz P; Grabarek BO
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928253
[TBL] [Abstract][Full Text] [Related]
37. First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent.
Allen JE; Crowder RN; El-Deiry WS
PLoS One; 2015; 10(11):e0143082. PubMed ID: 26580220
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors.
He Y; Li J; Koga T; Ma J; Dhawan S; Suzuki Y; Furnari F; Prabhu VV; Allen JE; Chen CC
Neuro Oncol; 2021 Mar; 23(3):400-411. PubMed ID: 32830856
[TBL] [Abstract][Full Text] [Related]
39. Effect on the expression of
Genis-Mendoza AD; Tovilla-Zárate CA; López-Narvaez L; Mendoza-Lorenzo P; Ostrosky-Wegman P; Nicolini H; González-Castro TB; Hernández-Diaz Y
Hereditas; 2016; 153():13. PubMed ID: 28096775
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms.
Wagner J; Kline CL; Zhou L; Khazak V; El-Deiry WS
J Exp Clin Cancer Res; 2018 Jan; 37(1):11. PubMed ID: 29357916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
